Effects of erythropoietin on immune function of tumor-bearing mice
Yue Liu
Abstract
Yue Liu
Abstract
Objective:To study the effects of erythropoietin(EPO) on immune function in a murine melanoma model.Methods:C57BL/6 mice were randomly divided into 3 groups: normal control group,saline-treated group and EPO-treated group.Mice of saline-treated group and EPO-treated group were inoculated with melanoma cell B16.The changes of red blood cell(RBC),hemoglobin(Hb),hematocrit(Hct) and white blood cell(WBC) in peripheral blood,spleen index were observed.The subpopulations of CD4+ and CD8+ T-cell in mice spleen was performed by flow cytomery.Serum concentrations of interleukin(IL)-2 and tumor necrosis factor(TNF)-α of 3 groups was measured by ELISA.Results:A significantly greater reduction in the levels of RBC,Hb and Hct in peripheral blood was observed in saline-treated mice compared to the normal control mice(P 0.05).EPO treatment increased the levels of RBC,Hb and Hct in peripheral blood and spleen index in tumor-bearing mice(P 0.05).The levels of WBC in peripheral blood was not different in 3 groups(P0.05);CD4+ T-cell percentage and CD4+/CD8+ ratio of spleen cell was significantly decreased in tumor-bearing mice compared to the normal control group(P 0.05).CD4+ T-cell percentage of mice spleen was not different(P0.05),but CD8+ T-cell percentage was significantly decreased leading to increase of the CD4+/CD8+ ratio in EPO-treated group compared to the saline-treated group(P 0.05);the serum concentrations of IL-2 and TNF-α was significantly decreased in tumor-bearing group compared to the normal control group(P 0.05).The concentration of IL-2 was significantly increased in EPO-treated group compared to the saline-treated group(P 0.05),while that of TNF-α was not different in both study groups(P0.05).Conclusion:These results suggest that EPO treatment can correct the anemia,and also improve immune function in tumor-bearing mice by increasing the CD4+/CD8+ ratio and IL-2 concentrations of peripheral blood.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the effects of erythropoietin(EPO) on immune function in a murine melanoma model.Methods:C57BL/6 mice were randomly divided into 3 groups: normal control group,saline-treated group and EPO-treated group.Mice of saline-treated group and EPO-treated group were inoculated with melanoma cell B16.The changes of red blood cell(RBC),hemoglobin(Hb),hematocrit(Hct) and white blood cell(WBC) in peripheral blood,spleen index were observed.The subpopulations of CD4+ and CD8+ T-cell in mice spleen was performed by flow cytomery.Serum concentrations of interleukin(IL)-2 and tumor necrosis factor(TNF)-α of 3 groups was measured by ELISA.Results:A significantly greater reduction in the levels of RBC,Hb and Hct in peripheral blood was observed in saline-treated mice compared to the normal control mice(P 0.05).EPO treatment increased the levels of RBC,Hb and Hct in peripheral blood and spleen index in tumor-bearing mice(P 0.05).The levels of WBC in peripheral blood was not different in 3 groups(P0.05);CD4+ T-cell percentage and CD4+/CD8+ ratio of spleen cell was significantly decreased in tumor-bearing mice compared to the normal control group(P 0.05).CD4+ T-cell percentage of mice spleen was not different(P0.05),but CD8+ T-cell percentage was significantly decreased leading to increase of the CD4+/CD8+ ratio in EPO-treated group compared to the saline-treated group(P 0.05);the serum concentrations of IL-2 and TNF-α was significantly decreased in tumor-bearing group compared to the normal control group(P 0.05).The concentration of IL-2 was significantly increased in EPO-treated group compared to the saline-treated group(P 0.05),while that of TNF-α was not different in both study groups(P0.05).Conclusion:These results suggest that EPO treatment can correct the anemia,and also improve immune function in tumor-bearing mice by increasing the CD4+/CD8+ ratio and IL-2 concentrations of peripheral blood.
Key concepts: Spleen, Erythropoietin, CD8, Internal medicine, Endocrinology, Hematocrit, Immune system, White blood cell